Nvigen specializes in advanced technologies centered around molecularly engineered nanoparticles, which are pivotal in the fields of cancer diagnostics and therapeutics. Their flagship products include the MagVigen™ magnetic nanoparticles, which facilitate high-efficiency DNA capture, purification, and immunoprecipitation. These nanoparticles are designed for various applications, including cell-free DNA extraction, protein purification, and cell separation, all while maintaining high recovery rates and minimal disruption to biological systems. Additionally, the company offers MyQuVigen™, which combines magnetic and fluorescent properties for enhanced imaging and detection, and MaxVigen™, which focuses on in vivo imaging and targeted drug delivery.

Another significant innovation from Nvigen is the NERNST-Seq™ technology, which allows for spatial and temporal resolution in single-cell RNA sequencing, providing unprecedented insights into cellular dynamics. Their AuVigen™ gold nanoparticles are also noteworthy, offering biocompatibility and stability for biological sensing and therapeutic applications. Overall, Nvigen's commitment to developing multifunctional and biodegradable nanoparticles is aimed at empowering personalized medicine and revolutionizing healthcare through improved cancer care and diagnostics.

United States

NVIGEN is a nanobiotechnology company that specializes in multifunctional nanoparticles for biomedical applications through their proprietary NID platform.

Nvigen

Company Details